PCM
TBIO

Penserra Capital Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Penserra Capital Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,715
Closed -$47K – 1569
2021
Q2 		$47K Buy
1,715
+35
+2% +$688 ﹤0.01% 1022
2021
Q1 		$27K Sell
1,680
-40
-2% -$911 ﹤0.01% 923
2020
Q4 		$31K Buy
1,720
+1,086
+171% +$19.4K ﹤0.01% 773
2020
Q3 		$8K Buy
+634
New +$9.77K ﹤0.01% 843

Penserra Capital Management's TBIO Position: Q3 2021 in Review

Penserra Capital Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 1,715 shares — an estimated $47K sold.

Penserra Capital Management first reported a position in TBIO in Q3 2020 and held it in 4 quarters. The position peaked at $47K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Penserra Capital Management reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Penserra Capital Management sold 1,715 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $47K.
  • Penserra Capital Management first reported a position in Translate Bio, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
  • Penserra Capital Management's Translate Bio, Inc. Common Stock position peaked at $47K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Penserra Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.